NCT06079333
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Ellen Kapiteijn Leiden, South Holland, Netherlands
Clinical trial condition
Thyroid Carcinoma, Anaplastic
Explore clinical trials studying Thyroid Carcinoma, Anaplastic. Study availability and eligibility vary by location and protocol.
57 public trials
11 recruiting studies
Thyroid Carcinoma, Anaplastic trial results
Not yet recruiting
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
NCT07470489
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Taiwanese Anaplastic Thyroid Cancer Registry
NCT07138261
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- Taipei Veterans General Hospital Taipei, Taiwan/Taipei, Taiwan
- Kaohsiung Medical University Kaohsiung City, Taiwan
- National Taiwan University Hospital ,NTUH Hsin-Chu Branch Sindian City, Taiwan
- China Medical University Hospital Taichung, Taiwan
NCT05557045
- Conditions
- Advanced Cancer, Anaplastic Thyroid Cancer (ATC), Bronchial Neoplasms, +39 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- SCRI HealthOne Denver, Colorado, United States
- Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
Active, not recruiting
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
NCT07485569
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Differentiated Thyroid Cancer, +12 more
- Locations
-
- Radboudumc Nijmegen, Netherlands
Active, not recruiting
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
NCT04675710
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- Stanford School of Medicine Stanford, California, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States
- Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States
Active, not recruiting
Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer
NCT04171622
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
NCT03085056
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
Active, not recruiting
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
NCT04238624
- Conditions
- Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States